Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock? (Q50513841)
Jump to navigation
Jump to search
scientific article published in March 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock? |
scientific article published in March 2000 |
Statements
Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock? (English)
1 reference
Evora PR
1 reference
1 March 2000
1 reference
119
1 reference
3
1 reference
632-634
1 reference
1 reference
1 reference